Suzanne Egyhazi Brage (Suzanne Egyhàzi Brage, Suzanne Egyházi Brage)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cell death & disease

Cancer research

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Max J Karlsson, Fernanda Costa Svedman, Abdellah Tebani, David Kotol, Veronica Höiom, Linn Fagerberg, Fredrik Edfors, Mathias Uhlén, Suzanne Egyhazi Brage, Gianluca Maddalo
Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy. Cancer research 81 (9) (2021)
Ishani Das, Helge Gad, Lars Bräutigam, Linda Pudelko, Rainer Tuominen, Veronica Höiom, Ingrid Almlöf, Varshni Rajagopal, Johan Hansson, Thomas Helleday, Suzanne Egyhazi Brage, Ulrika Warpman Berglund
AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma. Cell death and differentiation 27 (7) (2020)
Ishani Das, Huiqin Chen, Gianluca Maddalo, Rainer Tuominen, Vito W Rebecca, Meenhard Herylyn, Johan Hansson, Michael A Davies, Suzanne Egyhazi Brage
Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma. Cell death & disease 11 (10) (2020)
Ishani Das, Margareta Wilhelm, Veronica Höiom, Rodolfo Franco, Fernanda Costa Svedman, Johan Hansson, Rainer Tuominen, Suzanne Egyhazi Brage
Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status. Cell death & disease 10 (9) (2019)
Alireza Azimi, Rainer Tuominen, Fernanda Costa Svedman, Stefano Caramuta, Maria Pernemalm, Marianne Frostvik Stolt, Lena Kanter, Pedram Kharaziha, Janne Lehtiö, Carolina Hertzman Johansson, Veronica Höiom, Johan Hansson, Suzanne Egyhazi Brage
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. Cell death & disease 8 (8) (2017)